No changes in serum anthranilic acid (AA) and 3-hydroxyanthranilic acid (3-HAA) levels were detected at 2 and 4 weeks during IFN-α therapy in both depression (+) and depression (−) patients (Table 2). Here, IFNA1 is linked to major depressive disorder.